Yi‐Yu Ke

547 total citations
24 papers, 422 citations indexed

About

Yi‐Yu Ke is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Yi‐Yu Ke has authored 24 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Cell Biology. Recurrent topics in Yi‐Yu Ke's work include Microtubule and mitosis dynamics (6 papers), Multiple Myeloma Research and Treatments (3 papers) and Chemokine receptors and signaling (3 papers). Yi‐Yu Ke is often cited by papers focused on Microtubule and mitosis dynamics (6 papers), Multiple Myeloma Research and Treatments (3 papers) and Chemokine receptors and signaling (3 papers). Yi‐Yu Ke collaborates with scholars based in Taiwan, India and China. Yi‐Yu Ke's co-authors include Jen‐Shin Song, Lun K. Tsou, Thy‐Hou Lin, Chiung‐Tong Chen, Kak‐Shan Shia, Chuan Shih, Teng‐Kuang Yeh, Jing‐Kai Huang, Chun‐Ping Chang and Mine-Hsine Wu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Cancer Research.

In The Last Decade

Yi‐Yu Ke

24 papers receiving 416 citations

Peers

Yi‐Yu Ke
Xiaomin Ni Germany
Michele F. Rega United States
Yongping Zhu China
Lixian Wu China
Stephan Miller United States
Yongping Cui China
Shan‐Liang Sun China
Robert R. Lavieri United States
Christine Basmadjian France
Mohammed I. El–Gamal United Arab Emirates
Xiaomin Ni Germany
Yi‐Yu Ke
Citations per year, relative to Yi‐Yu Ke Yi‐Yu Ke (= 1×) peers Xiaomin Ni

Countries citing papers authored by Yi‐Yu Ke

Since Specialization
Citations

This map shows the geographic impact of Yi‐Yu Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Yu Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Yu Ke more than expected).

Fields of papers citing papers by Yi‐Yu Ke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi‐Yu Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Yu Ke. The network helps show where Yi‐Yu Ke may publish in the future.

Co-authorship network of co-authors of Yi‐Yu Ke

This figure shows the co-authorship network connecting the top 25 collaborators of Yi‐Yu Ke. A scholar is included among the top collaborators of Yi‐Yu Ke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi‐Yu Ke. Yi‐Yu Ke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Chun‐Ping, Teng‐Kuang Yeh, Chiung‐Tong Chen, et al.. (2024). Discovery of a Long Half-Life AURKA Inhibitor to Treat MYC-Amplified Solid Tumors as a Monotherapy and in Combination with Everolimus. Molecular Cancer Therapeutics. 23(6). 766–779. 4 indexed citations
2.
3.
Yao, Chun‐Hsu, Zhao‐Qing Shen, Yuwen Huang, et al.. (2023). Discovery of tetrasubstituted thiophenes as Cisd2 activators: A potential novel therapeutic option in nonalcoholic fatty liver disease. European Journal of Medicinal Chemistry. 258. 115583–115583. 2 indexed citations
4.
5.
Kuppusamy, Ramajayam, Yi‐Yu Ke, Yuhao Lin, et al.. (2022). Benzo[b]thiophene-2-carboxamides as novel opioid receptor agonists with potent analgesic effect and reduced constipation. European Journal of Medicinal Chemistry. 243. 114728–114728. 6 indexed citations
6.
Song, Jen‐Shin, Chih-Chun Chang, Kuan‐Wei Huang, et al.. (2021). A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment. Proceedings of the National Academy of Sciences. 118(13). 60 indexed citations
7.
Fang, Mingyu, et al.. (2021). Chemoproteomic profiling reveals cellular targets of nitro-fatty acids. Redox Biology. 46. 102126–102126. 14 indexed citations
8.
Tsou, Lun K., Shiu‐Hwa Yeh, Shau‐Hua Ueng, et al.. (2020). Comparative study between deep learning and QSAR classifications for TNBC inhibitors and novel GPCR agonist discovery. Scientific Reports. 10(1). 16771–16771. 71 indexed citations
9.
Ke, Yi‐Yu, Chun‐Ping Chang, Wen‐Hsing Lin, et al.. (2018). Design and synthesis of BPR1K653 derivatives targeting the back pocket of Aurora kinases for selective isoform inhibition. European Journal of Medicinal Chemistry. 151. 533–545. 10 indexed citations
10.
Song, Jen‐Shin, Szu‐Huei Wu, Lun K. Tsou, et al.. (2018). Development of Stem-Cell-Mobilizing Agents Targeting CXCR4 Receptor for Peripheral Blood Stem Cell Transplantation and Beyond. Journal of Medicinal Chemistry. 61(3). 818–833. 10 indexed citations
11.
Yeh, Teng‐Kuang, Ching‐Chuan Kuo, Yue‐Zhi Lee, et al.. (2017). Design, Synthesis, and Evaluation of Thiazolidine-2,4-dione Derivatives as a Novel Class of Glutaminase Inhibitors. Journal of Medicinal Chemistry. 60(13). 5599–5612. 30 indexed citations
12.
Cheng, Chia‐Yi, Chun‐Ping Chang, Tsai-Ling Yang Lauderdale, et al.. (2016). Bromomethylthioindole Inspired Carbazole Hybrids as Promising Class of Anti-MRSA Agents. ACS Medicinal Chemistry Letters. 7(12). 1191–1196. 18 indexed citations
13.
Ke, Yi‐Yu, et al.. (2015). Latifolicinin A from a Fermented Soymilk Product and the Structure–Activity Relationship of Synthetic Analogues as Inhibitors of Breast Cancer Cell Growth. Journal of Agricultural and Food Chemistry. 63(44). 9715–9721. 14 indexed citations
14.
Lin, Chih-Ru, Hsien‐Yu Tsai, Chia‐Jung Chen, et al.. (2015). The immunologically active oligosaccharides isolated from wheatgrass modulate monocytes via Toll-like receptor-2 signaling.. Journal of Biological Chemistry. 290(19). 11935–11935. 3 indexed citations
15.
Ke, Yi‐Yu, et al.. (2014). Abstract 2530: Optimization of 5,6-fused pyrimidine-based kinase inhibitors by computer-aided drug design for the treatment of AML. Cancer Research. 74(19_Supplement). 2530–2530. 1 indexed citations
16.
Lin, Chih-Ru, Hsien‐Yu Tsai, Chia‐Jung Chen, et al.. (2013). The Immunologically Active Oligosaccharides Isolated from Wheatgrass Modulate Monocytes via Toll-like Receptor-2 Signaling. Journal of Biological Chemistry. 288(24). 17689–17697. 32 indexed citations
17.
Coumar, Mohane Selvaraj, Yi‐Yu Ke, Ya‐Hui Chi, et al.. (2013). Optimization of Ligand and Lipophilic Efficiency To Identify an in Vivo Active Furano-Pyrimidine Aurora Kinase Inhibitor. Journal of Medicinal Chemistry. 56(13). 5247–5260. 38 indexed citations
18.
Ke, Yi‐Yu, Chang‐Ying Chu, Yen‐Chun Lee, et al.. (2012). 3D‐QSAR‐Assisted Drug Design: Identification of a Potent Quinazoline‐Based Aurora Kinase Inhibitor. ChemMedChem. 8(1). 136–148. 23 indexed citations
19.
Ke, Yi‐Yu, Yun‐Chu Chen, & Thy‐Hou Lin. (2006). Structure of the virus capsid protein VP1 of enterovirus 71 predicted by some homology modeling and molecular docking studies. Journal of Computational Chemistry. 27(13). 1556–1570. 8 indexed citations
20.
Ke, Yi‐Yu & Thy‐Hou Lin. (2004). A theoretical study on the activation of Ser70 in the acylation mechanism of cephalosporin antibiotics. Biophysical Chemistry. 114(2-3). 103–113. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaomin Ni Breakdown of academic impact, for papers by Michele F. Rega Breakdown of academic impact, for papers by Yongping Zhu Breakdown of academic impact, for papers by Lixian Wu Breakdown of academic impact, for papers by Stephan Miller Breakdown of academic impact, for papers by Yongping Cui Breakdown of academic impact, for papers by Shan‐Liang Sun Breakdown of academic impact, for papers by Robert R. Lavieri Breakdown of academic impact, for papers by Christine Basmadjian Breakdown of academic impact, for papers by Mohammed I. El–Gamal
Rankless by CCL
2026